BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2025.
World J Gastrointest Surg. Sep 27, 2025; 17(9): 109152
Published online Sep 27, 2025. doi: 10.4240/wjgs.v17.i9.109152
Table 3 Univariate analysis of efficacy predictors, n (%)
Factor
Ineffective group (n = 16)
Effective group (n = 83)
χ2
P value
Gender0.2340.629
    Male (n = 67)10 (62.50)57 (68.67)
    Female (n = 32)6 (37.50)26 (31.33)
Age (years)-0.014
    < 55 (n = 47)3 (18.75)44 (53.01)
    ≥ 55 (n = 52)13 (81.25)39 (46.99)
Cirrhosis duration (years)-0.013
    < 4 (n = 40)2 (12.50)38 (45.78)
    ≥ 4 (n = 59)14 (87.50)45 (54.22)
Child-Pugh grade1.5530.213
    A (n = 45)5 (31.25)40 (48.19)
    B/C (n = 54)11 (68.75)43 (51.81)
Bleeding duration (hour)5.6340.018
    < 24 (n = 63)6 (37.50)57 (68.67)
    ≥ 24 (n = 36)10 (62.50)26 (31.33)
Bleeding volume (mL)0.1590.690
    < 600 (n = 54)8 (50.00)46 (55.42)
    ≥ 600 (n = 45)8 (50.00)37 (44.58)
Treatment approach-0.031
    Endoscopic variceal ligation (n = 49)12 (75.00)37 (44.58)
    Endoscopic variceal ligation + propranolol (n = 50)4 (25.00)46 (55.42)


Write to the Help Desk